These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 21186845)

  • 1. LC-MS based serum metabonomic analysis for renal cell carcinoma diagnosis, staging, and biomarker discovery.
    Lin L; Huang Z; Gao Y; Yan X; Xing J; Hang W
    J Proteome Res; 2011 Mar; 10(3):1396-405. PubMed ID: 21186845
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hydrophilic interaction and reversed-phase ultraperformance liquid chromatography TOF-MS for serum metabonomic analysis of myocardial infarction in rats and its applications.
    Tan G; Lou Z; Liao W; Dong X; Zhu Z; Li W; Chai Y
    Mol Biosyst; 2012 Feb; 8(2):548-56. PubMed ID: 22037674
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Integrated ionization approach for RRLC-MS/MS-based metabonomics: finding potential biomarkers for lung cancer.
    An Z; Chen Y; Zhang R; Song Y; Sun J; He J; Bai J; Dong L; Zhan Q; Abliz Z
    J Proteome Res; 2010 Aug; 9(8):4071-81. PubMed ID: 20560663
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Application of SELDI-TOF-MS to identify serum biomarkers for renal cell carcinoma.
    Xu G; Xiang CQ; Lu Y; Kang XN; Liao P; Ding Q; Zhang YF
    Cancer Lett; 2009 Sep; 282(2):205-13. PubMed ID: 19362769
    [TBL] [Abstract][Full Text] [Related]  

  • 5. (1)H NMR metabonomic analysis in renal cell carcinoma: a possible diagnostic tool.
    Zira AN; Theocharis SE; Mitropoulos D; Migdalis V; Mikros E
    J Proteome Res; 2010 Aug; 9(8):4038-44. PubMed ID: 20527959
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Wnt antagonist family genes as biomarkers for diagnosis, staging, and prognosis of renal cell carcinoma using tumor and serum DNA.
    Urakami S; Shiina H; Enokida H; Hirata H; Kawamoto K; Kawakami T; Kikuno N; Tanaka Y; Majid S; Nakagawa M; Igawa M; Dahiya R
    Clin Cancer Res; 2006 Dec; 12(23):6989-97. PubMed ID: 17145819
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential protein expressions in renal cell carcinoma: new biomarker discovery by mass spectrometry.
    Siu KW; DeSouza LV; Scorilas A; Romaschin AD; Honey RJ; Stewart R; Pace K; Youssef Y; Chow TF; Yousef GM
    J Proteome Res; 2009 Aug; 8(8):3797-807. PubMed ID: 19610612
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A comprehensive urinary metabolomic approach for identifying kidney cancerr.
    Kind T; Tolstikov V; Fiehn O; Weiss RH
    Anal Biochem; 2007 Apr; 363(2):185-95. PubMed ID: 17316536
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Direct infusion mass spectrometry or liquid chromatography mass spectrometry for human metabonomics? A serum metabonomic study of kidney cancer.
    Lin L; Yu Q; Yan X; Hang W; Zheng J; Xing J; Huang B
    Analyst; 2010 Nov; 135(11):2970-8. PubMed ID: 20856980
    [TBL] [Abstract][Full Text] [Related]  

  • 10. LC-MS-based serum metabolic profiling for genitourinary cancer classification and cancer type-specific biomarker discovery.
    Lin L; Huang Z; Gao Y; Chen Y; Hang W; Xing J; Yan X
    Proteomics; 2012 Aug; 12(14):2238-46. PubMed ID: 22685041
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comprehensive untargeted metabonomic analysis of human steatotic liver tissue by RP and HILIC chromatography coupled to mass spectrometry reveals important metabolic alterations.
    García-Cañaveras JC; Donato MT; Castell JV; Lahoz A
    J Proteome Res; 2011 Oct; 10(10):4825-34. PubMed ID: 21830829
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Elevated serum-circulating RNA in patients with conventional renal cell cancer.
    Feng G; Li G; Gentil-Perret A; Tostain J; Genin C
    Anticancer Res; 2008; 28(1A):321-6. PubMed ID: 18383864
    [TBL] [Abstract][Full Text] [Related]  

  • 13. RRLC-MS/MS-based metabonomics combined with in-depth analysis of metabolic correlation network: finding potential biomarkers for breast cancer.
    Chen Y; Zhang R; Song Y; He J; Sun J; Bai J; An Z; Dong L; Zhan Q; Abliz Z
    Analyst; 2009 Oct; 134(10):2003-11. PubMed ID: 19768207
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Value of global metabolomics in association with diagnosis and clinicopathological factors of renal cell carcinoma.
    Sato T; Kawasaki Y; Maekawa M; Takasaki S; Saigusa D; Ota H; Shimada S; Yamashita S; Mitsuzuka K; Yamaguchi H; Ito A; Kinoshita K; Koshiba S; Mano N; Arai Y
    Int J Cancer; 2019 Jul; 145(2):484-493. PubMed ID: 30628065
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of two new serum protein profiles for renal cell carcinoma.
    Engwegen JY; Mehra N; Haanen JB; Schellens JH; Voest EE; Beijnen JH
    Oncol Rep; 2009 Aug; 22(2):401-8. PubMed ID: 19578783
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Marker for renal cell carcinoma (RCC): the dimeric form of pyruvate kinase type M2 (Tu M2-PK).
    Wechsel HW; Petri E; Bichler KH; Feil G
    Anticancer Res; 1999; 19(4A):2583-90. PubMed ID: 10470199
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A metabonomic study of hepatitis B-induced liver cirrhosis and hepatocellular carcinoma by using RP-LC and HILIC coupled with mass spectrometry.
    Yin P; Wan D; Zhao C; Chen J; Zhao X; Wang W; Lu X; Yang S; Gu J; Xu G
    Mol Biosyst; 2009 Aug; 5(8):868-76. PubMed ID: 19603122
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Time-course changes in potential biomarkers detected using a metabonomic approach in Walker 256 tumor-bearing rats.
    Shen G; Chen Y; Sun J; Zhang R; Zhang Y; He J; Tian Y; Song Y; Chen X; Abliz Z
    J Proteome Res; 2011 Apr; 10(4):1953-61. PubMed ID: 21275377
    [TBL] [Abstract][Full Text] [Related]  

  • 19. LC-MS based metabolomic profiling for renal cell carcinoma histologic subtypes.
    Jing L; Guigonis JM; Borchiellini D; Durand M; Pourcher T; Ambrosetti D
    Sci Rep; 2019 Oct; 9(1):15635. PubMed ID: 31666664
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum protein profiling to identify biomarkers for small renal cell carcinoma.
    Xu G; Hou CR; Jiang HW; Xiang CQ; Shi N; Yuan HC; Ding Q; Zhang YF
    Indian J Biochem Biophys; 2010 Aug; 47(4):211-8. PubMed ID: 21174948
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.